Anders Bengtsson
81 – 90 of 190
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Novel risk genes for systemic lupus erythematosus predicted by random forest classification
(
- Contribution to journal › Article
-
Mark
Endothelial dysfunction is associated with activation of the type I interferon system and platelets in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity
(
- Contribution to journal › Article
-
Mark
Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.
(
- Contribution to journal › Article
- 2016
-
Mark
The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study
(
- Contribution to journal › Article
-
Mark
The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
(
- Contribution to journal › Article
-
Mark
Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
(
- Contribution to journal › Article
-
Mark
Variations in the epidemiology of systemic lupus erythematosus in southern Sweden.
2016) In Lupus(
- Contribution to journal › Article
-
Mark
Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.
(
- Contribution to journal › Article